世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Neonatal Intensive Care - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neonatal Intensive Care was estimated to be worth US$ 1245 million in 2024 and is forecast to a readjusted size of US$ 1715 million by 2031 with a CAGR of 4.4% during the fore... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Neonatal Intensive Care was estimated to be worth US$ 1245 million in 2024 and is forecast to a readjusted size of US$ 1715 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.Neonatal Intensive Care refers to the specialized medical care provided to critically ill or premature newborns in a Neonatal Intensive Care Unit (NICU). These units are equipped with advanced medical technologies, such as incubators, ventilators, and neonatal monitors, to support the fragile health of newborns with low birth weight, respiratory distress, infections, or congenital conditions. NICUs play a crucial role in improving survival rates and long-term health outcomes for high-risk infants through continuous monitoring and specialized medical interventions. Market Driver: The neonatal intensive care market is driven by the rising prevalence of preterm births, increasing neonatal complications, and advancements in neonatal care technology. With premature birth rates increasing globally due to factors such as maternal age, lifestyle changes, and medical conditions like diabetes and hypertension, the demand for neonatal intensive care units (NICUs) has grown significantly. Additionally, innovations in medical equipment, such as advanced incubators, ventilators, and neonatal monitoring systems, have improved the survival rates of critically ill newborns. Government initiatives and healthcare investments aimed at improving neonatal care further support market growth, particularly in developing regions. Market Challenge: Despite its expansion, the neonatal intensive care market faces challenges such as high treatment costs, limited accessibility in low-income regions, and a shortage of specialized healthcare professionals. The cost of NICU services, including advanced medical equipment and prolonged hospital stays, can be a significant financial burden for families and healthcare systems. Furthermore, disparities in healthcare infrastructure result in inadequate NICU facilities in many developing countries, limiting access to essential neonatal care. Additionally, the shortage of trained neonatologists and neonatal nurses remains a critical issue, affecting the quality of care and patient outcomes. This report aims to provide a comprehensive presentation of the global market for Neonatal Intensive Care, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neonatal Intensive Care by region & country, by Type, and by Application. The Neonatal Intensive Care market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neonatal Intensive Care. Market Segmentation By Company GE Healthcare Philips Dragerwerk Getinge Baxter Yuwell Hedy Medical Device Beijing Aeonmed Mindray Edan Instruments Micomme Medical Technology Development BLT Shenzhen Comen Hamerton Medtronic Fresenius Nihon Kohden Stryker ICU Medical B. Braun Zhengzhou Dison Ningbo David Segment by Type Baby Care Equipment Ventilator Monitor Others Segment by Application Public Hospital Private Hospital By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Neonatal Intensive Care company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Revenue of Neonatal Intensive Care in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Revenue of Neonatal Intensive Care in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Neonatal Intensive Care Product Introduction 1.2 Global Neonatal Intensive Care Market Size Forecast (2020-2031) 1.3 Neonatal Intensive Care Market Trends & Drivers 1.3.1 Neonatal Intensive Care Industry Trends 1.3.2 Neonatal Intensive Care Market Drivers & Opportunity 1.3.3 Neonatal Intensive Care Market Challenges 1.3.4 Neonatal Intensive Care Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Neonatal Intensive Care Players Revenue Ranking (2024) 2.2 Global Neonatal Intensive Care Revenue by Company (2020-2025) 2.3 Key Companies Neonatal Intensive Care Manufacturing Base Distribution and Headquarters 2.4 Key Companies Neonatal Intensive Care Product Offered 2.5 Key Companies Time to Begin Mass Production of Neonatal Intensive Care 2.6 Neonatal Intensive Care Market Competitive Analysis 2.6.1 Neonatal Intensive Care Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by Neonatal Intensive Care Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neonatal Intensive Care as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Baby Care Equipment 3.1.2 Ventilator 3.1.3 Monitor 3.1.4 Others 3.2 Global Neonatal Intensive Care Sales Value by Type 3.2.1 Global Neonatal Intensive Care Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Neonatal Intensive Care Sales Value, by Type (2020-2031) 3.2.3 Global Neonatal Intensive Care Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Public Hospital 4.1.2 Private Hospital 4.2 Global Neonatal Intensive Care Sales Value by Application 4.2.1 Global Neonatal Intensive Care Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Neonatal Intensive Care Sales Value, by Application (2020-2031) 4.2.3 Global Neonatal Intensive Care Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global Neonatal Intensive Care Sales Value by Region 5.1.1 Global Neonatal Intensive Care Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Neonatal Intensive Care Sales Value by Region (2020-2025) 5.1.3 Global Neonatal Intensive Care Sales Value by Region (2026-2031) 5.1.4 Global Neonatal Intensive Care Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America Neonatal Intensive Care Sales Value, 2020-2031 5.2.2 North America Neonatal Intensive Care Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe Neonatal Intensive Care Sales Value, 2020-2031 5.3.2 Europe Neonatal Intensive Care Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific Neonatal Intensive Care Sales Value, 2020-2031 5.4.2 Asia Pacific Neonatal Intensive Care Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America Neonatal Intensive Care Sales Value, 2020-2031 5.5.2 South America Neonatal Intensive Care Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa Neonatal Intensive Care Sales Value, 2020-2031 5.6.2 Middle East & Africa Neonatal Intensive Care Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Neonatal Intensive Care Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Neonatal Intensive Care Sales Value, 2020-2031 6.3 United States 6.3.1 United States Neonatal Intensive Care Sales Value, 2020-2031 6.3.2 United States Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Neonatal Intensive Care Sales Value, 2020-2031 6.4.2 Europe Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Neonatal Intensive Care Sales Value, 2020-2031 6.5.2 China Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.5.3 China Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Neonatal Intensive Care Sales Value, 2020-2031 6.6.2 Japan Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Neonatal Intensive Care Sales Value, 2020-2031 6.7.2 South Korea Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Neonatal Intensive Care Sales Value, 2020-2031 6.8.2 Southeast Asia Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Neonatal Intensive Care Sales Value, 2020-2031 6.9.2 India Neonatal Intensive Care Sales Value by Type (%), 2024 VS 2031 6.9.3 India Neonatal Intensive Care Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 GE Healthcare 7.1.1 GE Healthcare Profile 7.1.2 GE Healthcare Main Business 7.1.3 GE Healthcare Neonatal Intensive Care Products, Services and Solutions 7.1.4 GE Healthcare Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.1.5 GE Healthcare Recent Developments 7.2 Philips 7.2.1 Philips Profile 7.2.2 Philips Main Business 7.2.3 Philips Neonatal Intensive Care Products, Services and Solutions 7.2.4 Philips Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.2.5 Philips Recent Developments 7.3 Dragerwerk 7.3.1 Dragerwerk Profile 7.3.2 Dragerwerk Main Business 7.3.3 Dragerwerk Neonatal Intensive Care Products, Services and Solutions 7.3.4 Dragerwerk Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.3.5 Dragerwerk Recent Developments 7.4 Getinge 7.4.1 Getinge Profile 7.4.2 Getinge Main Business 7.4.3 Getinge Neonatal Intensive Care Products, Services and Solutions 7.4.4 Getinge Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.4.5 Getinge Recent Developments 7.5 Baxter 7.5.1 Baxter Profile 7.5.2 Baxter Main Business 7.5.3 Baxter Neonatal Intensive Care Products, Services and Solutions 7.5.4 Baxter Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.5.5 Baxter Recent Developments 7.6 Yuwell 7.6.1 Yuwell Profile 7.6.2 Yuwell Main Business 7.6.3 Yuwell Neonatal Intensive Care Products, Services and Solutions 7.6.4 Yuwell Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.6.5 Yuwell Recent Developments 7.7 Hedy Medical Device 7.7.1 Hedy Medical Device Profile 7.7.2 Hedy Medical Device Main Business 7.7.3 Hedy Medical Device Neonatal Intensive Care Products, Services and Solutions 7.7.4 Hedy Medical Device Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.7.5 Hedy Medical Device Recent Developments 7.8 Beijing Aeonmed 7.8.1 Beijing Aeonmed Profile 7.8.2 Beijing Aeonmed Main Business 7.8.3 Beijing Aeonmed Neonatal Intensive Care Products, Services and Solutions 7.8.4 Beijing Aeonmed Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.8.5 Beijing Aeonmed Recent Developments 7.9 Mindray 7.9.1 Mindray Profile 7.9.2 Mindray Main Business 7.9.3 Mindray Neonatal Intensive Care Products, Services and Solutions 7.9.4 Mindray Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.9.5 Mindray Recent Developments 7.10 Edan Instruments 7.10.1 Edan Instruments Profile 7.10.2 Edan Instruments Main Business 7.10.3 Edan Instruments Neonatal Intensive Care Products, Services and Solutions 7.10.4 Edan Instruments Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.10.5 Edan Instruments Recent Developments 7.11 Micomme Medical Technology Development 7.11.1 Micomme Medical Technology Development Profile 7.11.2 Micomme Medical Technology Development Main Business 7.11.3 Micomme Medical Technology Development Neonatal Intensive Care Products, Services and Solutions 7.11.4 Micomme Medical Technology Development Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.11.5 Micomme Medical Technology Development Recent Developments 7.12 BLT 7.12.1 BLT Profile 7.12.2 BLT Main Business 7.12.3 BLT Neonatal Intensive Care Products, Services and Solutions 7.12.4 BLT Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.12.5 BLT Recent Developments 7.13 Shenzhen Comen 7.13.1 Shenzhen Comen Profile 7.13.2 Shenzhen Comen Main Business 7.13.3 Shenzhen Comen Neonatal Intensive Care Products, Services and Solutions 7.13.4 Shenzhen Comen Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.13.5 Shenzhen Comen Recent Developments 7.14 Hamerton 7.14.1 Hamerton Profile 7.14.2 Hamerton Main Business 7.14.3 Hamerton Neonatal Intensive Care Products, Services and Solutions 7.14.4 Hamerton Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.14.5 Hamerton Recent Developments 7.15 Medtronic 7.15.1 Medtronic Profile 7.15.2 Medtronic Main Business 7.15.3 Medtronic Neonatal Intensive Care Products, Services and Solutions 7.15.4 Medtronic Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.15.5 Medtronic Recent Developments 7.16 Fresenius 7.16.1 Fresenius Profile 7.16.2 Fresenius Main Business 7.16.3 Fresenius Neonatal Intensive Care Products, Services and Solutions 7.16.4 Fresenius Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.16.5 Fresenius Recent Developments 7.17 Nihon Kohden 7.17.1 Nihon Kohden Profile 7.17.2 Nihon Kohden Main Business 7.17.3 Nihon Kohden Neonatal Intensive Care Products, Services and Solutions 7.17.4 Nihon Kohden Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.17.5 Nihon Kohden Recent Developments 7.18 Stryker 7.18.1 Stryker Profile 7.18.2 Stryker Main Business 7.18.3 Stryker Neonatal Intensive Care Products, Services and Solutions 7.18.4 Stryker Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.18.5 Stryker Recent Developments 7.19 ICU Medical 7.19.1 ICU Medical Profile 7.19.2 ICU Medical Main Business 7.19.3 ICU Medical Neonatal Intensive Care Products, Services and Solutions 7.19.4 ICU Medical Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.19.5 ICU Medical Recent Developments 7.20 B. Braun 7.20.1 B. Braun Profile 7.20.2 B. Braun Main Business 7.20.3 B. Braun Neonatal Intensive Care Products, Services and Solutions 7.20.4 B. Braun Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.20.5 B. Braun Recent Developments 7.21 Zhengzhou Dison 7.21.1 Zhengzhou Dison Profile 7.21.2 Zhengzhou Dison Main Business 7.21.3 Zhengzhou Dison Neonatal Intensive Care Products, Services and Solutions 7.21.4 Zhengzhou Dison Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.21.5 Zhengzhou Dison Recent Developments 7.22 Ningbo David 7.22.1 Ningbo David Profile 7.22.2 Ningbo David Main Business 7.22.3 Ningbo David Neonatal Intensive Care Products, Services and Solutions 7.22.4 Ningbo David Neonatal Intensive Care Revenue (US$ Million) & (2020-2025) 7.22.5 Ningbo David Recent Developments 8 Industry Chain Analysis 8.1 Neonatal Intensive Care Industrial Chain 8.2 Neonatal Intensive Care Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Neonatal Intensive Care Sales Model 8.5.2 Sales Channel 8.5.3 Neonatal Intensive Care Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
